$VTAK
Catheter Precision, Inc.

2018 Q3 Form 10-Q Financial Statement

#000156459018029383 Filed on November 14, 2018

View on sec.gov

Income Statement

Concept 2018 Q3 2017 Q3
Revenue $2.064M $1.291M
YoY Change 59.88%
Cost Of Revenue $1.280M $693.0K
YoY Change 84.7%
Gross Profit $784.0K $598.0K
YoY Change 31.1%
Gross Profit Margin 37.98% 46.32%
Selling, General & Admin $5.366M $1.904M
YoY Change 181.83%
% of Gross Profit 684.44% 318.39%
Research & Development $224.0K $413.0K
YoY Change -45.76%
% of Gross Profit 28.57% 69.06%
Depreciation & Amortization $200.0K $100.0K
YoY Change 100.0%
% of Gross Profit 25.51% 16.72%
Operating Expenses $5.590M $2.317M
YoY Change 141.26%
Operating Profit -$4.806M -$1.719M
YoY Change 179.58%
Interest Expense $1.000K $1.000K
YoY Change 0.0%
% of Operating Profit
Other Income/Expense, Net -$1.000K
YoY Change
Pretax Income -$4.807M -$1.720M
YoY Change 179.48%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$4.807M
YoY Change
Net Earnings / Revenue -232.9%
Basic Earnings Per Share
Diluted Earnings Per Share -$585.9K
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2018 Q3 2017 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $4.915M
YoY Change
Cash & Equivalents $4.915M $972.0K
Short-Term Investments $0.00
Other Short-Term Assets $237.0K
YoY Change
Inventory $1.281M
Prepaid Expenses
Receivables $1.346M
Other Receivables $0.00
Total Short-Term Assets $7.779M
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $2.809M
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $3.601M
YoY Change
Total Long-Term Assets $6.410M
YoY Change
TOTAL ASSETS
Total Short-Term Assets $7.779M
Total Long-Term Assets $6.410M
Total Assets $14.19M
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.340M
YoY Change
Accrued Expenses $1.640M
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due $30.00K
YoY Change
Total Short-Term Liabilities $6.833M
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities $107.0K
YoY Change
Total Long-Term Liabilities $107.0K
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $6.833M
Total Long-Term Liabilities $107.0K
Total Liabilities $7.708M
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings -$45.28M
YoY Change
Common Stock $51.77M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $6.481M
YoY Change
Total Liabilities & Shareholders Equity $14.19M
YoY Change

Cashflow Statement

Concept 2018 Q3 2017 Q3
OPERATING ACTIVITIES
Net Income -$4.807M
YoY Change
Depreciation, Depletion And Amortization $200.0K $100.0K
YoY Change 100.0%
Cash From Operating Activities -$4.139M -$1.250M
YoY Change 231.12%
INVESTING ACTIVITIES
Capital Expenditures -$174.0K -$40.00K
YoY Change 335.0%
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities -$174.0K -$40.00K
YoY Change 335.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -539.0K 1.310M
YoY Change -141.15%
NET CHANGE
Cash From Operating Activities -4.139M -1.250M
Cash From Investing Activities -174.0K -40.00K
Cash From Financing Activities -539.0K 1.310M
Net Change In Cash -4.852M 20.00K
YoY Change -24360.0%
FREE CASH FLOW
Cash From Operating Activities -$4.139M -$1.250M
Capital Expenditures -$174.0K -$40.00K
Free Cash Flow -$3.965M -$1.210M
YoY Change 227.69%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2018Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3601000
CY2018Q3 us-gaap Assets
Assets
14189000
CY2018Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
3340000
CY2018Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1640000
CY2018Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4915000
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8237000
CY2018Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1346000
CY2017Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
517000
CY2018Q3 us-gaap Inventory Net
InventoryNet
1281000
CY2017Q4 us-gaap Inventory Net
InventoryNet
1196000
CY2018Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
237000
CY2017Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
92000
CY2018Q3 us-gaap Assets Current
AssetsCurrent
7779000
CY2017Q4 us-gaap Assets Current
AssetsCurrent
10042000
CY2018Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2809000
CY2017Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1159000
CY2017Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
68000
CY2017Q4 us-gaap Assets
Assets
11269000
CY2017Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
426000
CY2017Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
324000
CY2017Q4 rmed Equipment Financing Obligations Current
EquipmentFinancingObligationsCurrent
44000
CY2018Q3 us-gaap Liabilities Current
LiabilitiesCurrent
6833000
CY2017Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2633000
CY2017Q4 rmed Equipment Financing Obligations Noncurrent
EquipmentFinancingObligationsNoncurrent
19000
CY2017Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
81000
CY2018Q3 us-gaap Liabilities
Liabilities
7708000
CY2017Q4 us-gaap Liabilities
Liabilities
18884000
CY2017Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1751000
CY2017Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1714000
CY2018Q3 rmed Equipment Financing Obligations Current
EquipmentFinancingObligationsCurrent
30000
CY2018Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
72000
CY2017Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
125000
CY2018Q3 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
768000
CY2017Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
775000
CY2017Q4 us-gaap Deferred Compensation Sharebased Arrangements Liability Classified Noncurrent
DeferredCompensationSharebasedArrangementsLiabilityClassifiedNoncurrent
15376000
CY2018Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
107000
CY2018Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q3 us-gaap Common Stock Value
CommonStockValue
1000
CY2017Q4 us-gaap Common Stock Value
CommonStockValue
1000
CY2018Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
51764000
CY2017Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
21773000
CY2018Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-45284000
CY2017Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-29389000
CY2018Q3 us-gaap Stockholders Equity
StockholdersEquity
6481000
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
-7615000
CY2018Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
14189000
CY2017Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
11269000
CY2018Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2017Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2018Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
25000000
CY2017Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
25000000
CY2018Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
8204251
CY2017Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7888170
CY2018Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
8204251
CY2017Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7888170
CY2018Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2064000
CY2017Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1291000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4269000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3933000
CY2018Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1280000
CY2017Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
693000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
15621000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
11932000
CY2018Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
224000
CY2017Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
413000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1532000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4159000
CY2018Q3 us-gaap Operating Expenses
OperatingExpenses
5590000
CY2017Q3 us-gaap Operating Expenses
OperatingExpenses
2317000
us-gaap Operating Expenses
OperatingExpenses
17153000
us-gaap Operating Expenses
OperatingExpenses
16091000
CY2018Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-4806000
CY2017Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1719000
us-gaap Operating Income Loss
OperatingIncomeLoss
-15890000
us-gaap Operating Income Loss
OperatingIncomeLoss
-14665000
CY2018Q3 us-gaap Interest Expense
InterestExpense
1000
CY2017Q3 us-gaap Interest Expense
InterestExpense
1000
CY2017Q3 us-gaap Cost Of Revenue
CostOfRevenue
693000
us-gaap Cost Of Revenue
CostOfRevenue
3006000
us-gaap Interest Expense
InterestExpense
2000
us-gaap Interest Expense
InterestExpense
3000
CY2018Q3 us-gaap Interest And Debt Expense
InterestAndDebtExpense
1000
CY2017Q3 us-gaap Interest And Debt Expense
InterestAndDebtExpense
1000
us-gaap Interest And Debt Expense
InterestAndDebtExpense
2000
us-gaap Interest And Debt Expense
InterestAndDebtExpense
3000
CY2018Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4807000
CY2017Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1720000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-15892000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-14668000
CY2018Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1000
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
-4807000
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.97
CY2018Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
8204000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
7469000
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
7901000
rmed Settlement Of Stock Based Compensation Liability
SettlementOfStockBasedCompensationLiability
18243000
rmed Adjustments To Additional Paid In Capital Share Based Compensation Forfeitures Of Liability Classified Awards
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationForfeituresOfLiabilityClassifiedAwards
1313000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2534000
us-gaap Profit Loss
ProfitLoss
-15895000
us-gaap Profit Loss
ProfitLoss
-14669000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
388000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
147000
us-gaap Share Based Compensation
ShareBasedCompensation
6714000
us-gaap Share Based Compensation
ShareBasedCompensation
11528000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
829000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-269000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1699000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1134000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
122000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
20000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
695000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
323000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
636000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-143000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
30000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-319000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-27000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-10109000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4018000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
424000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
275000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-424000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-275000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
7901000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1377000
rmed Payments On Equipment Financing
PaymentsOnEquipmentFinancing
33000
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
657000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
7211000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1344000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-3322000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-2949000
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3921000
CY2017Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
972000
rmed Deferred Initial Public Offering Costs In Accounts Payable And Accrued Expenses
DeferredInitialPublicOfferingCostsInAccountsPayableAndAccruedExpenses
2899000
rmed Transfer From Inventories To Property And Equipment For Demonstration Lasers Lasers And Lasers Placed With Customers
TransferFromInventoriesToPropertyAndEquipmentForDemonstrationLasersLasersAndLasersPlacedWithCustomers
1614000
rmed Transfer From Inventories To Property And Equipment For Demonstration Lasers Lasers And Lasers Placed With Customers
TransferFromInventoriesToPropertyAndEquipmentForDemonstrationLasersLasersAndLasersPlacedWithCustomers
239000
us-gaap Interest Paid Net
InterestPaidNet
1000
us-gaap Interest Paid Net
InterestPaidNet
1000
CY2018Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2018Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
25000000
CY2018Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
10000000
CY2018Q3 us-gaap Deferred Offering Costs
DeferredOfferingCosts
3600000
CY2017Q4 us-gaap Deferred Offering Costs
DeferredOfferingCosts
0
CY2018Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
1051000
CY2017Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
705000
CY2018Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
37000
CY2017Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
110000
CY2018Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
193000
CY2017Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
381000
CY2018Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3917000
CY2017Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1934000
CY2018Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1108000
CY2017Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
775000
CY2018Q3 us-gaap Depreciation
Depreciation
200000
CY2017Q3 us-gaap Depreciation
Depreciation
100000
us-gaap Depreciation
Depreciation
400000
us-gaap Depreciation
Depreciation
100000
CY2018Q3 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
45000
CY2017Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
68000
CY2018Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
702000
CY2017Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
236000
CY2018Q3 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
50000
CY2017Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
87000
CY2018Q3 rmed Accrued Initial Public Offering Costs
AccruedInitialPublicOfferingCosts
680000
CY2018Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
208000
CY2017Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1000
CY2016Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
97000
us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
60000
CY2017 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
198000
us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
97000
CY2017 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
208000
CY2018Q3 us-gaap Product Warranty Expense
ProductWarrantyExpense
30000
us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
316080
CY2018Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1453000
CY2017Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
569000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6320000
CY2017Q3 us-gaap Revenues
Revenues
1291000
us-gaap Revenues
Revenues
4269000
us-gaap Revenues
Revenues
3933000
CY2018Q3 us-gaap Cost Of Revenue
CostOfRevenue
1280000
us-gaap Cost Of Revenue
CostOfRevenue
2507000
CY2017Q3 us-gaap Product Warranty Expense
ProductWarrantyExpense
30000
us-gaap Product Warranty Expense
ProductWarrantyExpense
100000
us-gaap Product Warranty Expense
ProductWarrantyExpense
100000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
10840000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P2Y8M12D
CY2018Q3 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
100000
CY2017Q3 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
100000
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
200000
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
300000
CY2018Q3 us-gaap Operating Leases Future Minimum Payments Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
122000
CY2018Q3 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
500000
CY2018Q3 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
514000
CY2018Q3 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
528000
CY2018Q3 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
432000
CY2018Q3 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
2363000
CY2018Q3 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
4459000
CY2017 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
200000
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2
CY2018Q3 us-gaap Revenues
Revenues
2064000

Files In Submission

Name View Source Status
0001564590-18-029383-index-headers.html Edgar Link pending
0001564590-18-029383-index.html Edgar Link pending
0001564590-18-029383.txt Edgar Link pending
0001564590-18-029383-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
rmed-10q_20180930.htm Edgar Link pending
rmed-20180930.xml Edgar Link completed
rmed-20180930.xsd Edgar Link pending
rmed-20180930_cal.xml Edgar Link unprocessable
rmed-20180930_def.xml Edgar Link unprocessable
rmed-20180930_lab.xml Edgar Link unprocessable
rmed-20180930_pre.xml Edgar Link unprocessable
rmed-ex101_86.htm Edgar Link pending
rmed-ex102_87.htm Edgar Link pending
rmed-ex311_82.htm Edgar Link pending
rmed-ex312_83.htm Edgar Link pending
rmed-ex321_84.htm Edgar Link pending
rmed-ex322_85.htm Edgar Link pending
Show.js Edgar Link pending